News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,378 Results
Type
Article (14271)
Company Profile (305)
Press Release (250802)
Section
Business (80235)
Career Advice (175)
Deals (13364)
Drug Delivery (34)
Drug Development (50576)
Employer Resources (33)
FDA (5731)
Job Trends (5197)
News (145525)
Policy (10147)
Tag
Academia (929)
Alliances (21767)
Alzheimer's disease (762)
Approvals (5707)
Artificial intelligence (70)
Bankruptcy (98)
Best Places to Work (4572)
Biotechnology (250)
Breast cancer (109)
Cancer (891)
Cardiovascular disease (74)
Career advice (151)
CAR-T (74)
Cell therapy (219)
Clinical research (40321)
Collaboration (313)
Compensation (128)
COVID-19 (1025)
C-suite (79)
Cystic fibrosis (66)
Data (989)
Diabetes (87)
Diagnostics (1248)
Drug discovery (56)
Earnings (29312)
Events (47645)
Executive appointments (247)
FDA (6100)
Funding (311)
Gene editing (63)
Gene therapy (164)
GLP-1 (315)
Government (1086)
Healthcare (6647)
Infectious disease (1062)
Inflammatory bowel disease (99)
IPO (7271)
Job creations (890)
Job search strategy (145)
Layoffs (195)
Legal (1409)
Lung cancer (130)
Lymphoma (62)
Manufacturing (87)
Medical device (2654)
Medtech (2655)
Mergers & acquisitions (6231)
Metabolic disorders (260)
Neuroscience (1007)
NextGen Class of 2024 (2055)
Non-profit (882)
Northern California (1093)
Obesity (141)
Opinion (92)
Parkinson's disease (75)
Patents (62)
People (25349)
Phase I (14206)
Phase II (18736)
Phase III (11886)
Pipeline (371)
Postmarket research (864)
Preclinical (5991)
Radiopharmaceuticals (206)
Rare diseases (203)
Real estate (1439)
Regulatory (8363)
Research institute (957)
Series A (55)
Southern California (979)
Startups (1978)
United States (8716)
Vaccines (176)
Weight loss (84)
Date
Last 7 days (366)
Last 30 days (1405)
Last 365 days (20686)
2024 (20597)
2023 (22617)
2022 (27051)
2021 (28078)
2020 (23870)
2019 (16602)
2018 (12041)
2017 (13981)
2016 (12059)
2015 (14603)
2014 (10521)
2013 (7568)
2012 (7621)
2011 (7708)
2010 (7504)
Location
Africa (158)
Asia (17153)
Australia (2900)
California (2481)
Canada (811)
China (203)
Colorado (91)
Connecticut (104)
Europe (37276)
Florida (271)
Georgia (71)
Illinois (159)
Indiana (63)
Maryland (332)
Massachusetts (1975)
Minnesota (103)
New Jersey (633)
New York (685)
North Carolina (421)
Northern California (1093)
Ohio (83)
Pennsylvania (477)
South America (225)
Southern California (979)
Texas (279)
Washington State (250)
265,378 Results for "horizon therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Theranexus Presents an Update of its Cash Position and Financing Horizon
December 17, 2024
·
4 min read
Huntington’s
After Decades of Failure, First Disease-Modifying Huntington’s Treatment on the Horizon
The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies including Prilenia and Wave Life Sciences eye paths to approval of therapies that could address the underlying cause of the disease.
November 11, 2024
·
7 min read
·
Heather McKenzie
Press Releases
Magstim Horizon Inspire Transcranial Magnetic Stimulation Device Approved by UKCA for NHS & Private UK Clinics
December 5, 2024
·
2 min read
Drug Development
Beacon Therapeutics Presents 36-Month Interim Results from Phase I/2 HORIZON Trial of AGTC-501 in Patients with XLRP
September 19, 2024
·
2 min read
Genetown
Nested Therapeutics to Present Preclinical Data for NST-628, a Novel Pan-RAF/MEK Molecular Glue, in the New Drugs on the Horizon Series at 2024 AACR Annual Meeting
Nested Therapeutics today announced that preclinical data from its lead program, NST-628, will be featured in an oral presentation in the “New Drugs on the Horizon” series at the American Association for Cancer Research (AACR) Annual Meeting taking place in San Diego, California from April 5-10, 2024.
March 28, 2024
·
2 min read
Press Releases
ONI Expands Horizons: Entering the Lipid Nanoparticle Research Market
September 17, 2024
·
2 min read
Press Releases
The Multiple Myeloma Research Foundation (MMRF) Announces the First Patient Enrolled in its Horizon Clinical Trials Program to Accelerate the Identification of Optimal Treatment Strategies for Multiple Myeloma
December 5, 2024
·
3 min read
Deals
AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC
Amgen (NASDAQ: AMGN) today announced that it has completed its acquisition of Horizon Therapeutics plc for $116.50 per share in cash, representing a transaction equity value of approximately $27.8 billion.
October 6, 2023
·
14 min read
Biotech Bay
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
Adicet Bio, Inc. today announced that Chen Schor, President and Chief Executive Officer will participate in a panel at the Canaccord Genuity Horizons in Oncology Virtual Conference being held April 15, 2024.
April 8, 2024
·
1 min read
Biotech Bay
RenovoRx to Present at the Canaccord Genuity Horizons in Oncology Virtual Conference on April 15, 2024
RenovoRx, Inc today announced that Shaun Bagai, RenovoRx’s Chief Executive Officer, will present at the Canaccord Genuity 2024 Horizons in Oncology Virtual Conference to be held on April 15, 2024.
April 5, 2024
·
7 min read
1 of 26,538
Next
